News
New Study Shows mRNA COVID-19 Vaccines Safe for Pregnant People: C-VIPER Pregnancy Registry Finds No Increased Risk of Spontaneous Abortion Waltham, MA, March 16, 2023 – CorEvitas, LLC (“CorEvitas”), a leading provider of syndicated registries, is pleased to share important safety information...Learn More
News
WALTHAM, MA — January 9, 2023 — CorEvitas, LLC, the leading sponsor of syndicated clinical registries in autoimmune and inflammatory diseases, has launched and is recruiting patients in a first-of-its-kind registry to evaluate the safety and effectiveness of newly approved therapies for patients...Learn More
News
Investment augments CorEvitas’ pharmacovigilance services to fulfill global regulatory requirements for the safety of medications and vaccines during pregnancy Waltham, MA and Los Angeles, CA, November 22, 2022 – CorEvitas, LLC (“CorEvitas”), an industry leader in syndicated registries, announced...Learn More
News
Waltham, MA and London, UK, July 6, 2022 — CorEvitas, LLC is excited to announce expanded services to include specialty EMR data through its Specialty EMR Data Business Unit. Health iQ Limited, a subsidiary of CorEvitas, has provided innovative real-world evidence solutions in the United Kingdom...Learn More